Access to patient population more important than price for Phase I outsourcing, says ISR

Reputation also scored highly for Phase I outsourcers

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s:



“Access to patient population more important than price for Phase I outsourcing, says ISR”



https://www.outsourcing-pharma.com/Clinical-Development/Access-to-patient-population-more-important-than-price-for-Phase-I-outsourcing-says-ISR